Literature DB >> 989537

The clinical course of diabetic nephropathy.

M J Kussman, H Goldstein, R E Gleason.   

Abstract

A retrospective record analysis of 112 juvenile-onset diabetics with nephropathy was conducted in order to determine their clinical course. The mean duration of diabetes at the onset of proteinuria was 17.3+/-6.0 years. Early renal failure appeared two years after the onset of protein-uria, and severe renal failure (mean serum creatinine level, 8.5+/-3.9 mg/100 ml) four years after the onset of proteinuria. The mean duration of life after the onset of severe renal failure was six months. The mortality was 53%, with 59% of the deaths attributable to renal failure and 36% to cardiovascular disease. All patients experienced progressive deterioration of renal function as well as the other complications of diabetes, the rate of progression being accelerated toward the end of the course. Juvenile onset diabetics should be considered for renal transplantation before the serum creatinine level reaches 8.5 mg/100 ml.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 989537

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  31 in total

1.  The treatment of diabetic kidney disease.

Authors:  F C Goetz; C M Kjellstrand
Journal:  Diabetologia       Date:  1979-11       Impact factor: 10.122

Review 2.  Diabetic nephropathy: worldwide epidemic and effects of current treatment on natural history.

Authors:  Peter Rossing
Journal:  Curr Diab Rep       Date:  2006-12       Impact factor: 4.810

3.  'Microalbuminuria' in type I (insulin-dependent) diabetic patients with and without retinopathy.

Authors:  R Miccoli; O Giampietro; G Penno; G Odello; R Anichini; A Bertolotto; L Cruschelli; S Bertoli; R Navalesi
Journal:  Acta Diabetol Lat       Date:  1989 Apr-Jun

4.  Angiotensin-converting enzyme gene polymorphisms and T2DM in a case-control association study of the Bahraini population.

Authors:  Einas M Al-Harbi; Eman M Farid; Khalid A Gumaa; Emad M Masuadi; Jaipaul Singh
Journal:  Mol Cell Biochem       Date:  2011-01-05       Impact factor: 3.396

5.  End-stage diabetic nephropathy.

Authors: 
Journal:  Br Med J       Date:  1978-10-28

6.  Hypertension, hyperkalaemia and abnormalities of the renin-angiotensin system in diabetes mellitus.

Authors:  J B Ferriss; P A Sullivan; H Gonggrijp; A A Long; D J O'Sullivan
Journal:  Ir J Med Sci       Date:  1979       Impact factor: 1.568

7.  Remission of nephrotic-range albuminuria reduces risk of end-stage renal disease and improves survival in type 2 diabetic patients.

Authors:  K Rossing; P K Christensen; P Hovind; H-H Parving
Journal:  Diabetologia       Date:  2005-09-17       Impact factor: 10.122

Review 8.  Therapeutic approaches to diabetic nephropathy--beyond the RAS.

Authors:  Beatriz Fernandez-Fernandez; Alberto Ortiz; Carmen Gomez-Guerrero; Jesus Egido
Journal:  Nat Rev Nephrol       Date:  2014-05-06       Impact factor: 28.314

9.  Uremia in diabetics: the prognosis improves.

Authors:  E A Friedman; M M Beyer
Journal:  Klin Wochenschr       Date:  1980-10-01

10.  Central role for sodium in the pathogenesis of blood pressure changes independent of angiotensin, aldosterone and catecholamines in type 1 (insulin-dependent) diabetes mellitus.

Authors:  B Feldt-Rasmussen; E R Mathiesen; T Deckert; J Giese; N J Christensen; L Bent-Hansen; M D Nielsen
Journal:  Diabetologia       Date:  1987-08       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.